$53.39
0.160.30%
At close: -
$53.39
00.00%
After Hours: 4:01 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for iRadimed (IRMD) was reported on October 31, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $0.42 to $0.45, compared to the estimated EPS of $0.40. Additionally, iRadimed forecasted revenue between $0.02B and $0.02B for the quarter.
Browse guidance and forecast on all stocks.